(Q35791905)

10 August 2017

1 reference

title

Occupational and environmental risk factors for Parkinson's disease (English)

1 reference

10 August 2017

1 reference

Lai BC

1

1 reference

10 August 2017

Marion SA

series ordinal

2

1 reference

10 August 2017

Teschke K

series ordinal

3

1 reference

10 August 2017

Tsui JK

series ordinal

4

1 reference

10 August 2017

language of work or name

1 reference

1 June 2002

1 reference

10 August 2017

13

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

10 August 2017

8

1 reference

10 August 2017

297-309

1 reference

10 August 2017

5

1 reference

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Kindreds of dominantly inherited Parkinson's disease: keys to the riddle

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease: a test of the multifactorial etiologic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Xenogenetics in multifactorial disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

1 reference

7 January 2021

The genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson disease in twins: an etiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Worldwide occurrence of Parkinson's disease: an updated review

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease in populations of African origin: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Epidemiologic study of Parkinson's disease in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental factors and Parkinson's disease: a case-control study in China

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease: a case-control study of occupational and environmental risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Follow-up study of early-life protective and risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental risk factors in siblings with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease and exposure to agricultural work and pesticide chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental antecedents of young-onset Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

A case-control study of Parkinson's disease in a horticultural region of British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental exposures in elderly Canadians with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental risk factors and Parkinson's disease: a case-control study in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Genetic and environmental risk factors for Parkinson's disease in a Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

1 reference

7 January 2021

Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Genetics, drugs and environmental factors in Parkinson's disease. A case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease mortality and pesticide exposure in California 1984-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Effect of heptachlor on hepatic mitochondrial oxidative phosphorylation in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Non-cholinergic toxicity of organophosphates in mammals: interaction of ethaphos with mitochondrial functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Mitochondrial dysfunction in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Pesticides: an important but underused model for the environmental health sciences

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

The effects of the phosphorothioate insecticide fenitrothion on mammalian cytochrome P450-dependent metabolism of estradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

The effect of tridiphane (2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane) on hepatic epoxide-metabolizing enzymes: indications of peroxisome proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Interaction of glutathione transferase P1-1 with captan and captafol

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Organochlorine insecticides in substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease and exposure to rural environmental factors: a population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Health implications of organics in groundwater

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Occupational exposures to metals as risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

A Family History of Parkinson’s Disease and Its Effect on Other PD Risk Factors

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Long term exposure to manganese in rural well water has no neurological effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Dietary factors in Parkinson's disease: the role of food groups and specific foods

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Adult nutrient intake as a risk factor for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Case-control study of early life dietary factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Alpha-tocopherol levels in brain are not altered in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Serum levels of beta-carotene and other carotenoids in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Memory of food intake in the distant past.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Prior history of head trauma in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Head trauma as a risk factor for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Environmental factors in the etiology of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Incidence and risk factors of Parkinson's disease in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Magnetic resonance spectroscopic study of parkinsonism related to boxing

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Trauma and movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Peripherally induced tremor and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

1918 INFLUENZA, ENCEPHALITIS LETHARGICA, PARKINSONISM

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Infection in childhood and neurological diseases in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Diagnosis and immediate prognosis of Japanese B encephalitis; observations based on more than 200 patients with detailed analysis of 65 serologically confirmed cases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Japanese encephalitis and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Acute parkinsonism in suspected herpes simplex encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Encephalitis lethargica-like illness in a five-year-old

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Basal ganglia calcification after mumps encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

The substantia nigra is a major target for neurovirulent influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Measles infection and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Parkinson's disease and the environment in early life.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Occupational risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Influenza virus antibodies in Parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Invasion of brain by neurovirulent influenza A virus after intranasal inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Tobacco consumption and mortality from cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Smoking and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Smoking and Parkinson's disease. An age-dependent risk effect? The EUROPARKINSON Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Smoking and Parkinson's disease: a dose-response relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Smoking-associated protection from Alzheimer's and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Smoking and Parkinson's disease: a case-control study in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Cigarette smoking and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

Nicotinic receptors and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900054-2

7 January 2021

10.1016/S1353-8020(01)00054-2

Identifiers

DOI

1 reference

10 August 2017

1 reference